Powder: -20°C for 3 years | In solvent: -80°C for 1 year
ASM-IN-1 is a potent, orally active inhibitor of acid sphingomyelinase (ASM) with an IC50 of 1.5 µM, demonstrating antiatherosclerotic and anti-inflammatory activity. It effectively reduces lipid plaques in the aortic arch and aorta, along with decreasing plasma ceramide concentrations and oxidized LDL (Ox-LDL) levels [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,520.00 | |
50 mg | 6-8 weeks | $ 1,980.00 | |
100 mg | 6-8 weeks | $ 2,500.00 |
Description | ASM-IN-1 is a potent, orally active inhibitor of acid sphingomyelinase (ASM) with an IC50 of 1.5 µM, demonstrating antiatherosclerotic and anti-inflammatory activity. It effectively reduces lipid plaques in the aortic arch and aorta, along with decreasing plasma ceramide concentrations and oxidized LDL (Ox-LDL) levels [1]. |
In vitro | ASM-IN-1 (compound 4i) does not affect cell growth in HUVEC [1]. ASM-IN-1 at concentrations of 0, 1, and 5 µM reduces the expression of IL-6 and TNF-α in HUVEC in a dose-dependent manner upon LPS stimulation [1]. Additionally, ASM-IN-1 at 5 µM decreases the expression of MCP-1 mRNA and normalizes IL-6 mRNA levels in the presence of Ox-LDL [1]. |
In vivo | ASM-IN-1, administered via intravenous injection at 1 mg/kg and orally at 10 mg/kg, demonstrated favorable pharmacokinetic properties in ICR mice with an oral bioavailability of 35.42% [1]. When given intraperitoneally at doses of 6, 12, and 40 mg/kg twice daily for a duration of 8 weeks, ASM-IN-1 exhibited anti-atherosclerotic activity by inhibiting ASM activity in mice [1]. |
Molecular Weight | 390.19 |
Formula | C16H12BrN3O4 |
CAS No. | 2913151-46-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
ASM-IN-1 2913151-46-7 Metabolism Phospholipase inhibitor inhibit